Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jan C Oosterwijk

Showing results (31-40 of 95) with videos related to

Pageof 10
Sort By:
International Journal of Cancer|November 28, 2008
Time to stop ovarian cancer screening in BRCA1/2 mutation carriers?Nienke M van der Velde, Marian J E Mourits, Henriëtte J G Arts, et al.
American Journal of Human Genetics|March 6, 2003
Autosomal recessive HEM/Greenberg skeletal dysplasia is caused by 3 beta-hydroxysterol delta 14-reductase deficiency due to mutations in the lamin B receptor geneHans R Waterham, Janet Koster, Petra Mooyer, et al.
Breast Cancer Research and Treatment|March 6, 2010
Penetrance of breast cancer, ovarian cancer and contralateral breast cancer in BRCA1 and BRCA2 families: high cancer incidence at older ageDorina M van der Kolk, Geertruida H de Bock, Beike K Leegte, et al.
Patient Education and Counseling|May 17, 2005
The decision evaluation scalesPeep F M Stalmeier, Marielle S Roosmalen, Lia C G Verhoef, et al.
Maturitas|November 15, 2011
Model of care for women at increased risk of breast and ovarian cancerGeertruida H De Bock, Jan Willem Hesselink, Carriene Roorda, et al.
Cancer Prevention Research (Philadelphia, Pa.)|September 27, 2012
Breast Cancer Incidence After Risk-Reducing Salpingo-Oophorectomy in BRCA1 and BRCA2 Mutation CarriersIngrid E Fakkert, Marian J E Mourits, Liesbeth Jansen, et al.
Pediatric Blood & Cancer|March 19, 2019
Multiple tumors due to mosaic genome-wide paternal uniparental disomyFloor A M Postema, Jet Bliek, Carel J M van Noesel, et al.
European Journal of Human Genetics : EJHG|July 9, 2009
The Dutch founder mutation SDHD.D92Y shows a reduced penetrance for the development of paragangliomas in a large multigenerational familyErik F Hensen, Jeroen C Jansen, Maaike D Siemers, et al.
International Journal of Cancer|March 31, 2015
Survival benefit in women with BRCA1 mutation or familial risk in the MRI screening study (MRISC)Sepideh Saadatmand, Inge-Marie Obdeijn, Emiel J Rutgers, et al.
Plos One|January 7, 2017
Elevated Bone Turnover Markers after Risk-Reducing Salpingo-Oophorectomy in Women at Increased Risk for Breast and Ovarian CancerIngrid E Fakkert, Eveline van der Veer, Elske Marije Abma, et al.
Pageof 10

Showing results (31-40 of 95) with videos related to

Sort By:
Pageof 10
International Journal of Cancer|November 28, 2008
Time to stop ovarian cancer screening in BRCA1/2 mutation carriers?Nienke M van der Velde, Marian J E Mourits, Henriëtte J G Arts, et al.
American Journal of Human Genetics|March 6, 2003
Autosomal recessive HEM/Greenberg skeletal dysplasia is caused by 3 beta-hydroxysterol delta 14-reductase deficiency due to mutations in the lamin B receptor geneHans R Waterham, Janet Koster, Petra Mooyer, et al.
Breast Cancer Research and Treatment|March 6, 2010
Penetrance of breast cancer, ovarian cancer and contralateral breast cancer in BRCA1 and BRCA2 families: high cancer incidence at older ageDorina M van der Kolk, Geertruida H de Bock, Beike K Leegte, et al.
Patient Education and Counseling|May 17, 2005
The decision evaluation scalesPeep F M Stalmeier, Marielle S Roosmalen, Lia C G Verhoef, et al.
Maturitas|November 15, 2011
Model of care for women at increased risk of breast and ovarian cancerGeertruida H De Bock, Jan Willem Hesselink, Carriene Roorda, et al.
Cancer Prevention Research (Philadelphia, Pa.)|September 27, 2012
Breast Cancer Incidence After Risk-Reducing Salpingo-Oophorectomy in BRCA1 and BRCA2 Mutation CarriersIngrid E Fakkert, Marian J E Mourits, Liesbeth Jansen, et al.
Pediatric Blood & Cancer|March 19, 2019
Multiple tumors due to mosaic genome-wide paternal uniparental disomyFloor A M Postema, Jet Bliek, Carel J M van Noesel, et al.
European Journal of Human Genetics : EJHG|July 9, 2009
The Dutch founder mutation SDHD.D92Y shows a reduced penetrance for the development of paragangliomas in a large multigenerational familyErik F Hensen, Jeroen C Jansen, Maaike D Siemers, et al.
International Journal of Cancer|March 31, 2015
Survival benefit in women with BRCA1 mutation or familial risk in the MRI screening study (MRISC)Sepideh Saadatmand, Inge-Marie Obdeijn, Emiel J Rutgers, et al.
Plos One|January 7, 2017
Elevated Bone Turnover Markers after Risk-Reducing Salpingo-Oophorectomy in Women at Increased Risk for Breast and Ovarian CancerIngrid E Fakkert, Eveline van der Veer, Elske Marije Abma, et al.
Pageof 10